- Home
- C vs TMO Comparison
C vs TMO Comparison
Compare C & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- C
- TMO
- Stock Information
- Founded
- C 1812
- TMO 1956
- Country
- C United States
- TMO United States
- Employees
- C N/A
- TMO N/A
- Industry
- C Major Banks
- TMO Industrial Machinery/Components
- Sector
- C Finance
- TMO Industrials
- Exchange
- C Nasdaq
- TMO Nasdaq
- Market Cap
- C 176.2B
- TMO 201.9B
- IPO Year
- C N/A
- TMO N/A
- Fundamental
- Price
- C $100.90
- TMO $561.62
- Analyst Decision
- C Buy
- TMO Buy
- Analyst Count
- C 15
- TMO 18
- Target Price
- C $104.63
- TMO $604.76
- AVG Volume (30 Days)
- C 14.4M
- TMO 2.5M
- Earning Date
- C 10-14-2025
- TMO 10-22-2025
- Dividend Yield
- C 2.38%
- TMO 0.30%
- EPS Growth
- C 103.92
- TMO 8.54
- EPS
- C 7.10
- TMO 17.32
- Revenue
- C $75,384,000,000.00
- TMO $43,736,000,000.00
- Revenue This Year
- C $23.37
- TMO $3.61
- Revenue Next Year
- C $3.12
- TMO $4.83
- P/E Ratio
- C $14.21
- TMO $32.56
- Revenue Growth
- C 9.16
- TMO 3.22
- 52 Week Low
- C $55.51
- TMO $385.46
- 52 Week High
- C $105.59
- TMO $610.97
- Technical
- Relative Strength Index (RSI)
- C 57.34
- TMO 66.84
- Support Level
- C $95.00
- TMO $561.04
- Resistance Level
- C $101.23
- TMO $578.24
- Average True Range (ATR)
- C 2.74
- TMO 10.89
- MACD
- C 0.26
- TMO 1.52
- Stochastic Oscillator
- C 85.25
- TMO 71.73
About C Citigroup Inc.
Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).